Cargando…
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas
BACKGROUND: CA19–9 is one of the most widely used tumor markers in biliary-pancreatic diseases. The measured value may not factually reflect the genuine CA19–9 level secreted by tumor, which affected by biliary obstruction. There is an urgent need of developing a correction formula of CA19–9 in bili...
Autores principales: | Zhao, Bangbo, Cheng, Qin, Cao, Hongtao, Zhou, Xingtong, Li, Tianhao, Dong, Liangbo, Wang, Weibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105938/ https://www.ncbi.nlm.nih.gov/pubmed/33962560 http://dx.doi.org/10.1186/s12885-021-08204-w |
Ejemplares similares
-
Percutaneous biliary drainage for obstructive jaundice in patients with inoperable, malignant biliary obstruction
por: Zerem, Enver, et al.
Publicado: (2022) -
Retrospective analysis of T-lymphocyte subsets and cytokines in malignant obstructive jaundice before and after external and internal biliary drainage
por: An, Jianli, et al.
Publicado: (2021) -
A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage
por: Sha, Junfeng, et al.
Publicado: (2019) -
Clinical outcomes and prediction of survival following percutaneous biliary drainage for malignant obstructive jaundice
por: ZHANG, GUANG YUAN, et al.
Publicado: (2014) -
Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review
por: Chandrashekhara, SH, et al.
Publicado: (2016)